Cell phenotype evaluation at various sites after skin transplantation and FTY720 plus sirolimus therapy.
Lopes
C T
CT
Nephrology Division, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Rosin
F C P
FC
Cordeiro
J A
JA
Bueno
V
V
D000818:Animals; D002452:Cell Count; D000068876:Fingolimod Hydrochloride; D005434:Flow Cytometry; D006085:Graft Survival / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007958:Leukocyte Count; D007962:Leukocytes / Q000166:cytology / Q000502:physiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D023421:Models, Animal; D010641:Phenotype; D011409:Propylene Glycols / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D012867:Skin / Q000166:cytology; D016038:Skin Transplantation / Q000276:immunology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D020123:Sirolimus